H-KAVYNFATM-OMe

Ref. 3D-PP46518

Produktinformation

• Name: H-KAVYNFATM-OMe
• Synonyme: NH2-Lys-Ala-Val-Tyr-Asn-Phe-Ala-Thr-Met-OMe

Beschreibung

Peptide H-KAVYNFATM-OMe is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-KAVYNFATM-OMe include the following: DetailedAnalysis of the CD8+ T-Cell Response followingAdenovirusVaccination TC Yang, K Dayball, YH Wan , J Bramson - Journal of virology, 2003 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.77.24.13407-13411.2003 A Structural Basis for CD8+ T Cell-dependent Recognition of Non-homologous Peptide Ligands T Sandalova , J Michaaca«lsson , RA Harris , J Odeberg - 2005 - academia.eduhttps://www.academia.edu/download/72285277/27069.full.pdf Structural bases underlying re-established recognition of a viral immune escape variant T Sandalova , E Allerbring, AD Duru , R Sun - Immunome , 2017 - search.proquest.comhttps://search.proquest.com/openview/6e4e590dd1285396ffb77ca351869b08/1?pq-origsite=gscholar&cbl=54870 Memory CD8+ T cells require CD8 coreceptor engagement for calcium mobilization and proliferation, but not cytokine production SE Kerry, R Maile , EJ Collins, JA Frelinger - Immunology, 2005 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/j.1365-2567.2004.02070.x CpG-DNA activates in vivo T cell epitope presenting dendritic cells to trigger protective antiviral cytotoxic T cell responses RM Vabulas, H Pircher , GB Lipford - The Journal of , 2000 - journals.aai.orghttps://journals.aai.org/jimmunol/article/164/5/2372/69663 T cells down-modulate peptide-MHC complexes on APCs in vivo RM Kedl , BC Schaefer , JW Kappler, P Marrack - Nature immunology, 2002 - nature.comhttps://www.nature.com/articles/ni742 Binding of H-2Kb-specific Peptides to TAP and Major Histocompatibility Complex Class I in Microsomes from Wild-type, TAP1, and beta2-Microglobulin Mutant Mice P Wang , C Raynoschek, K Svensson - Journal of Biological , 1996 - ASBMBhttps://www.jbc.org/article/S0021-9258(18)40080-4/abstract Rapid destruction of the tumor microenvironment by CTLs recognizing cancer-specific antigens cross-presented by stromal cells MT Spiotto, H Schreiber - Cancer immunity, 2005 - AACRhttps://aacrjournals.org/cancerimmun/article-abstract/5/1/8/472010 In Vivo Selection of a Lymphocytic Choriomeningitis Virus Variant That Affects Recognition of the GP33-43 Epitope by H-2Db but Not H-2Kb MT Puglielli, AJ Zajac, RG van der Most - Journal of , 2001 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/JVI.75.11.5099-5107.2001 Encapsulation of lipopeptides within liposomes: effect of number of lipid chains, chain length and method of liposome preparation MT Liang, NM Davies, I Toth - International journal of pharmaceutics, 2005 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0378517305004114 Intrathymic deletion of MHC class I-restricted cytotoxic T cell precursors by constitutive cross-presentation of exogenous antigen M Merkenschlager , MO Power - European journal of , 1999 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/(SICI)1521-4141(199905)29:05%3C1477::AID-IMMU1477%3E3.0.CO;2-3 Antigen presentation by exosomes released from peptide-pulsed dendritic cells is not suppressed by the presence of active CTL L Luketic, J Delanghe, PT Sobol, P Yang - The Journal of , 2007 - journals.aai.orghttps://journals.aai.org/jimmunol/article/179/8/5024/111573 In vivo generation of cytotoxic T cells from epitopes displayed on peptide-based delivery vehicles KS Kawamura, RC Su , LT Nguyen - The Journal of , 2002 - journals.aai.orghttps://journals.aai.org/jimmunol/article/168/11/5709/34240 Increased adjuvant activity of minimal CD8 T cell peptides incorporated into lipid-core-peptides K White, P Kearns, I Toth , S Hook - Immunology and cell , 2004 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/j.0818-9641.2004.01269.x Antigen Presentation by Exosomes Released J Bramson , Y Wan , EF Yang, KL Mossman , J Gauldie - J Immunol, 2007 - researchgate.nethttps://www.researchgate.net/profile/Jack-Gauldie/publication/5932590_Antigen_Presentation_by_Exosomes_Released_from_Peptide-Pulsed_Dendritic_Cells_Is_not_Suppressed_by_the_Presence_of_Active_CTL/links/56e2d70108ae387a2483a26f/Antigen-Presentation-by-Exosomes-Released-from-Peptide-Pulsed-Dendritic-Cells-Is-not-Suppressed-by-the-Presence-of-Active-CTL.pdf The MHC class I cancer-associated neoepitope Trh4 linked with impaired peptide processing induces a unique noncanonical TCR conformer I Hafstrand, EM Doorduijn, AD Duru - The Journal of , 2016 - journals.aai.orghttps://journals.aai.org/jimmunol/article/196/5/2327/102372 Effective antitumor peptide vaccines can induce severe autoimmune pathology H Sultan , J Trillo-Tinoco, P Rodriguez , E Celis - Oncotarget, 2017 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5642557/ T cell receptor sharing by cytotoxic T lymphocytes facilitates efficient virus control G Chaudhri, BJ Quah, Y Wang - Proceedings of the , 2009 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.0906554106 Dendritic cell (DC) dependent and DC independent generation of specific CD8+ T cell responses to MHC class I anchoring peptides. F Zipprich, S Wirth-Dulex, A Hugin - Journal of Investigative , 1997 - infona.plhttps://www.infona.pl/resource/bwmeta1.element.elsevier-45e8cbd2-5924-3c19-a5db-15bde8aed180 in the Immunodominant LCMV-Derived Epitope gp33 Highlights the Sensitivity of the TCR Recognition Mechanism for the MHC/Peptide Structure and Dynamics F Ballabio , L Broggini , C Paissoni , X Han, K Peqini - ACS , 2022 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acsomega.1c06964 Conformational analysis and rational design of tumor-associated altered peptide ligands F Ballabio , C Paissoni , C Camilloni - bioscienzebio.unimi.ithttps://bioscienzebio.unimi.it/phd/poster_file/2019-06-26_federico_ballabio.pdf 2D kinetic analysis of TCR and CD8 coreceptor for LCMV GP33 epitopes EM Kolawole , R Andargachew, B Liu - Frontiers in , 2018 - frontiersin.orghttps://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2018.02348/full Unexpected T-cell recognition of an altered peptide ligand is driven by reversed thermodynamics EB Allerbring, AD Duru , H Uchtenhagen - European journal of , 2012 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.201242588 Mature T cell reactivity altered by peptide agonist that induces positive selection. E Sebzda, TM Kundig, CT Thomson, K Aoki - The Journal of , 1996 - rupress.orghttps://rupress.org/jem/article-abstract/183/3/1093/47878 T cell immunity after a viral infection versus T cell tolerance induced by soluble viral peptides D Kyburz , P Aichele, DE Speiser - European journal of , 1993 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.1830230834 Murine CD8 T-cell functional avidity is stable in vivo but not in vitro: independence from homologous prime/boost time interval and antigen density CB Gilfillan, C Wang , MO Mohsen - European journal of , 2020 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.201948355 Protection against lymphocytic choriomeningitis virus infection induced by a reduced peptide bond analogue of the H-2Db-restricted CD8+ T cell epitope GP33 C Stemmer, A Quesnel, A Prevost-Blondel - Journal of Biological , 1999 - ASBMBhttps://www.jbc.org/article/S0021-9258(19)87693-7/abstract Cross-presentation of virus-like particles by skin-derived CD8- dendritic cells: a dispensable role for TAP C Ruedl , T Storni, F Lechner, T Bachi - European journal of , 2002 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/1521-4141(200203)32:3%3C818::AID-IMMU818%3E3.0.CO;2-U A structural basis for LCMV immune evasion: subversion of H-2Db and H-2Kb presentation of gp33 revealed by comparative crystal structure analyses A Achour , J Michaaca«lsson , RA Harris , J Odeberg - Immunity, 2002 - cell.comhttps://www.cell.com/immunity/pdf/S1074-7613(02)00478-8.pdf

• Marke: Biosynth